TOP PAGE
ENGLISH
JAPANESE
|
CONNECT WITH US:
Home
About
Services
Contact
Log in
*
Home
Press release
Aug 05, 2020 18:45 JST
Source:
Honda Motor Co, Ltd
Honda's Consolidated Financial Summary for the Fiscal Q1 Ended June 30, 2020 and Forecasts for the FY Ending March 31, 2021
- During the fiscal first quarter, business stagnated and demand declined significantly on a global basis due to the COVID-19. Production and sales activities of all Honda operations were impacted, as a result, sales and profit for the fiscal first quarter experienced a year-on-year decrease.
- Concerning the current fiscal year forecast, although the future outlook remains uncertain due to the impact of the COVID-19, Honda plans to achieve an operating profit of 200.0 billion yen and profit before income taxes of 365.0 billion yen by further strengthening its company-wide initiatives to improve earnings.
- Quarterly dividend for the fiscal first quarter will be 11 yen per share (a year-on-year decrease of 17 yen per share); total dividends paid for the fiscal year planned to be 44 yen per share.
TOKYO, Aug 05, 2020 - (JCN Newswire) - I. Consolidated Financial Summary and category of business results for the Fiscal 1st Quarter ended June 30, 2020
- Sales revenue: 2,123.7 billion yen (a year-on-year decrease by 46.9%) due primarily to a decrease in sales revenue from all businesses.
- Operating loss: 113.6 billion yen (a year-on-year decrease by 366.1 billion yen) due primarily to a decrease in profit related to changes in sales volume and model mix. This was despite a decrease in selling, general and administrative (SG&A) expenses.
- Loss before income taxes: 73.4 billion yen
The impact of the COVID-19 is estimated to be approximately 440.0 billion yen.
- Loss for the period attributable to owners of the parent: 80.8 billion yen (a year-on-year decrease by 253.1 billion yen).
(1) Motorcycle business
Sales revenue: 274.2 billion yen (a year-on-year decrease by 258.7 billion yen) due primarily to a decrease in unit sales mainly in Asia caused by the impact of the COVID-19.
Operating profit: 11.2 billion yen (a year-on-year decrease by 58.6 billion yen). Despite a decrease in unit sales, profit was secured due primarily to a decrease in R&D and SG&A expenses.
(2) Automobile business
Sales revenue: 1,255.7 billion yen (a year-on-year decrease by 1,494.4 billion yen) due to a decrease in sales especially in the U.S., Japan and India caused by the impact of the COVID-19.
Operating loss: 195.8 billion yen (a year-on-year decrease by 316.2 billion yen) due primarily to a decrease in unit sales. This was despite a decrease in SG&A expenses. Honda has been making progress in improving its business structure through cost and expense reductions even during this challenging time.
(3) Financial services business:
Operating profit: 71.5 billion yen (a year-on-year increase by 5.7 billion yen) due primarily to a difference in recorded amounts of provisions for credit losses.
(4) Life Creation (power products) and other businesses
Operating loss: 0.5 billion yen (a year-on-year improvement by 2.9 billion yen) due primarily to a decrease in R&D and SG&A expenses.
Aircraft and aircraft engine business, which is included in the other businesses, accounted for operating loss of 7.1 billion yen.
II. Forecasts for the for the Fiscal Year Ending March 31, 2021 (FY21)
Although the future outlook remains uncertain due to the impact of the COVID-19, Honda plans to achieve operating profit of 200.0 billion yen and profit before income taxes of 365.0 billion yen by further strengthening its initiatives to improve earnings.
Honda is expecting to recover from the unfavorable impact of the COVID-19 toward the end of the fiscal year; however, the current fiscal year forecast for profit before income tax includes an approximately 665.0 billion yen impact of the COVID-19.
Honda will strive to further enhance its earnings structure by making steady progress in on-going initiatives to improve its business structure.
For the full report, visit
https://global.honda/newsroom/news/2020/c200805eng.html
.
Source: Honda Motor Co, Ltd
Sectors: Automotive
Copyright ©2025 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Related Press Release
Honda to Launch New Heritage Service Business
December 12 2025 19:31 JST
Honda Technical Support for Red Bull Powertrains in F1 Racing Concludes
December 08 2025 15:34 JST
Honda Unveils Next-generation Technologies at "Honda Automotive Technology Workshop" for Electrified Models to be Launched in Second Half of 2020s
November 06 2025 21:44 JST
Honda Announces Electric Motorcycle Business Brand Promise and Four Core Values
November 04 2025 23:35 JST
Honda Unveils Its First Electric Motorcycle, the Honda WN7, at EICMA 2025
November 04 2025 23:20 JST
Honda Unveils V3R 900 E-Compressor Prototype Equipped with V3 Engine with Electronically-controlled Compressor at EICMA 2025
November 04 2025 23:00 JST
Honda Presents World Premiere of CB1000GT Sport Tourer at EICMA 2025
November 04 2025 22:55 JST
New CB1000GT, global debut of Honda WN7 electric motorcycle, expansion of Honda E-Clutch line-up and V3R 900 E-Compressor Prototype lead Honda's EICMA 2025 line-up
November 04 2025 22:40 JST
Honda Motorcycle Business Product Marks and New Emblem
November 04 2025 22:21 JST
Overview of Honda CEO Speech at the Japan Mobility Show 2025
October 30 2025 13:00 JST
More Press release >>
Latest Press Release
MHI Participates in Demonstration Testing of Vehicle-Infrastructure Integration System for Autonomous Buses in Shimotsuke City
Dec 19, 2025 03:24 JST
NEC and emaratech Collaborate on Biometric Smart Gates Supporting UAE Airport Operations
Dec 19, 2025 03:06 JST
Fujitsu to showcase mobility and physical AI tech at CES 2026
Dec 19, 2025 02:42 JST
Kirin and Fujitsu elucidate a novel gut-brain axis mechanism of citicoline for the first time worldwide through AI-based analysis and experimental validation leveraging drug discovery DX technology
Dec 19, 2025 02:06 JST
TANAKA PRECIOUS METAL GROUP and TANAKA MIRAI Lab. Released Their Fourth Collaborative Musical Work with Sound Wellness Lab (Della): "Precious Metal Orchestra - A Musical Voyage through the Sound of Precious Metals for Christmas" now available for streaming.
Dec 18, 2025 22:00 JST
PropertyGuru Asia Real Estate Summit spotlights PropertyGuru Week 2025 with conversations on 'Trusted Marketplaces and Thriving Communities'
Dec 18, 2025 10:00 JST
SAKENOVA: 28-Year-Old Master Brewer Pioneers AI-Driven Sake Revolution, Achieving 40% Cost Reduction While Winning International Gold Medals
Dec 15, 2025 23:00 JST
NEC Provides Vehicle Management Equipment for Autonomous Driving at Tokyo International Airport
Dec 15, 2025 19:41 JST
NEC and AEROTHAI Elevate Air Traffic Safety with Advanced Time Sync Solutions from Adtran Oscilloquartz
Dec 15, 2025 19:04 JST
Olympus Triples Venture Capital Fund Investment to Strengthen MedTech Leadership
Dec 15, 2025 08:30 JST
HKTDC 4Q25 Export Confidence Index: 2026 Hong Kong Export Growth of 8-9%, Sustained AI product demand lays solid foundation for future expansion
Dec 12, 2025 23:15 JST
Honda to Launch New Heritage Service Business
Dec 12, 2025 20:31 JST
Bank Mandiri Enhances Digital Resiliency for Financial Trading in Indonesia through Advanced Time Sync Solutions with NEC and Adtran Oscilloquartz
Dec 12, 2025 19:59 JST
NEC and ClimateAi sign a Memorandum of Understanding (MoU) for business co-creation to enhance climate resilience across various industries
Dec 12, 2025 18:13 JST
Anime Tokyo Station: A Series of Linked Events to Be Held in Conjunction with the Anniversary Joint Exhibition
Dec 12, 2025 11:00 JST
Eisai Rated "A", the Highest Rating by CDP in Both Climate Change and Water Security Categories for the Second Consecutive Year
Dec 11, 2025 19:41 JST
NEC Named to CDP's "A List" for Climate Change and Water Security for the Seventh Consecutive Year
Dec 11, 2025 19:00 JST
MHI Successfully Produces Hydrogen at Its Ammonia Cracking Pilot Plant Using Steam Heating
Dec 10, 2025 18:14 JST
NEC Presents Phase I Results for Personalized AI-Powered Oral Cancer Vaccine NECVAX-NEO1 at ESMO Immuno-Oncology Congress 2025
Dec 10, 2025 12:00 JST
"LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Included in China's Commercial Insurance Innovative Drug List
Dec 09, 2025 18:51 JST
More Latest Release >>